BioLife Solutions Inc (BLFS)
Debt-to-assets ratio
Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long-term debt | US$ in thousands | 18,311 | 20,937 | 23,572 | 23,692 | 23,793 | 24,207 | 6,188 | 6,313 | 6,353 | 6,122 | 5,019 | 916 | 655 | — | — | — | — | — | — | — |
Total assets | US$ in thousands | 412,714 | 411,152 | 433,177 | 446,470 | 450,229 | 488,020 | 470,681 | 544,279 | 554,286 | 559,391 | 520,969 | 240,024 | 234,829 | 195,887 | 113,970 | 94,987 | 92,816 | 83,789 | 51,303 | 48,073 |
Debt-to-assets ratio | 0.04 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2023 calculation
Debt-to-assets ratio = Long-term debt ÷ Total assets
= $18,311K ÷ $412,714K
= 0.04
The debt-to-assets ratio of BioLife Solutions Inc has remained relatively low and stable over the past several quarters, ranging from 0.00 to 0.05. This ratio indicates that the company relies minimally on debt financing to fund its operations and investments compared to its total assets. With the ratio consistently below 0.1, BioLife Solutions Inc appears to have a conservative debt structure, potentially reducing financial risk and enhancing financial flexibility. It suggests that the company may be managing its debt levels prudently and maintaining a healthy balance sheet.
Peer comparison
Dec 31, 2023
Company name
Symbol
Debt-to-assets ratio
BioLife Solutions Inc
BLFS
0.04
CONMED Corporation
CNMD
0.00
LivaNova PLC
LIVN
0.23
Masimo Corporation
MASI
0.29
Medtronic PLC
MDT
0.00
TransMedics Group Inc
TMDX
0.65